Vascular Stent
Vascular Stent Market by Product Type (Balloon-Expandable Stents, Self-Expanding Stents), Material (Metallic Stents, Polymeric Stents), Delivery System, Application, End User - Global Forecast 2024-2030
SKU
MRR-034B5003037F
Region
Global
Publication Date
November 2024
Delivery
Immediate
2023
USD 10.09 billion
2024
USD 10.65 billion
2030
USD 15.06 billion
CAGR
5.88%

The Vascular Stent Market size was estimated at USD 10.09 billion in 2023 and expected to reach USD 10.65 billion in 2024, at a CAGR 5.88% to reach USD 15.06 billion by 2030.

Vascular Stent Market
To learn more about this report, request a free PDF copy

Vascular stents are small, mesh-like tubes placed in blood vessels to keep them open and ensure smooth blood flow, primarily used in the treatment of conditions like coronary artery disease, peripheral artery disease, and other forms of vascular obstructions. The necessity for vascular stents arises from their vital role in preventing arterial collapse, improving blood circulation, and reducing the risk of heart attacks or strokes. Their applications span across coronary, peripheral, and neurovascular domains, with end-use in hospitals, ambulatory surgical centers, and specialized clinics. A key factor driving market growth is the increasing prevalence of cardiovascular diseases, coupled with an aging population and the rising adoption of minimally invasive surgical procedures. Technological advancements such as the development of bioresorbable stents represent potential opportunities, as they improve patient outcomes by eliminating issues related to long-term implantation. However, stringent regulatory frameworks, high costs associated with advanced stents, and potential complications post-surgery pose significant challenges. Potential areas of innovation include the development of drug-eluting stents with enhanced biocompatibility and smart stents with real-time monitoring capabilities. Implementing AI and machine learning in post-procedural diagnostics can further refine patient care. Additionally, expanding into emerging markets where the prevalence of cardiovascular diseases is growing opens lucrative avenues for growth. The market is moderately fragmented, characterized by intense competition and constant innovation, with major players focusing on R&D investments and strategic collaborations to maintain competitive advantage. Adopting strategies that cater to personalized medicine and focusing on patient-centered care can serve as viable recommendations for companies aiming to capitalize on emerging trends. Despite existing challenges, the vascular stent market holds promising potential, driven by a blend of medical necessity, technological advancements, and expanding global health initiatives.

Ask ResearchAI anything

World's First Innovative Al for Market Research

Ask your question about the Vascular Stent market, and ResearchAI will deliver precise answers.
How ResearchAI Enhances the Value of Your Research
ResearchAI-as-a-Service
Gain reliable, real-time access to a responsible AI platform tailored to meet all your research requirements.
24/7/365 Accessibility
Receive quick answers anytime, anywhere, so you’re always informed.
Maximize Research Value
Gain credits to improve your findings, complemented by comprehensive post-sales support.
Multi Language Support
Use the platform in your preferred language for a more comfortable experience.
Stay Competitive
Use AI insights to boost decision-making and join the research revolution at no extra cost.
Time and Effort Savings
Simplify your research process by reducing the waiting time for analyst interactions in traditional methods.

Market Dynamics

The market dynamics represent an ever-changing landscape of the Vascular Stent Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

  • Market Drivers
    • Expanding global prevalence of cardiovascular diseases
    • Increasing adoption of minimally invasive surgeries
  • Market Restraints
    • Concerns related to the long-term efficacy and safety of vascular stents among healthcare providers
  • Market Opportunities
    • Rising investments in research and development activities for innovation in stent designs
    • Integration of smart technology in vascular stents offering enhanced safety and efficacy
  • Market Challenges
    • Complexities associated with the stringent regulatory standards and approval procedures

Market Segmentation Analysis

  • Product Type: Growing preference for balloon-expandable stents for precision and effectiveness in navigating complex arterial paths

    Balloon-expandable stents, preferred for their precision and effectiveness in navigating complex arterial paths due to their controlled expansion through balloon inflation, are vital in coronary applications where accuracy is paramount. Self-expanding stents gained traction for their use in peripheral arteries and carotid arteries, where their characteristic nitinol-based flexibility and adaptive expansion without necessitating balloon assistance are crucial for catering to dynamic anatomical areas that experience higher movement or compression. Recent advancements, such as the development of bioresorbable stents and drug-eluting balloon-expandable stents, are noteworthy trends that emphasize the commitment to addressing restenosis and thrombosis concerns, increasing their appeal in clinical settings where long-term vessel patency is critical. The ease of deployment and reduced risk of vessel damage during placement emphasize their growing popularity. Recent news emphasizes a notable uptick in partnerships and collaborations among industry players to enhance product offerings through technology transfer and shared research initiatives, showcasing a dynamic approach to expanding the applications of self-expanding stents. Emerging applications are continuously evolving, with the integration of advanced imaging technologies and minimally invasive surgical techniques marking a significant change in how these devices are deployed and monitored post-placement. The exploration into using bioengineered coatings to improve compatibility and reduce inflammatory responses represents a significant frontier in stent innovation. Balloon-expandable stents and self-expanding stents are benefiting from developments in precision medicine, where tailoring stent design to individual patient anatomy and pathology better addresses the nuances of cardiovascular disease management. The choices between balloon-expandable and self-expanding stents are defined by clinical demands and the evolving capabilities of manufacturers to meet those needs with advanced products and comprehensive care solutions, promising a forward trajectory in enhancing patient outcomes and expanding clinical applications globally.

  • Material: Increasing utilization of metallic stents owing to their durability and efficacy in maintaining vascular patency

    Metallic stents, traditionally the mainstay due to their durability and proven efficacy in maintaining vascular patency, remain significant in the market with robust support from significant manufacturers that persist in innovating metallic compositions to enhance stent flexibility and biocompatibility. The polymeric stents, precisely dissected into biodegradable and non-biodegradable polymers, represent a growing paradigm shift aimed at addressing long-term complications associated with permanent implants. Biodegradable polymeric stents, hailed for their potential ability to dissolve harmlessly into the body post-therapeutic effect, have seen accelerated adoption. These innovations emphasize the growing preference for temporary scaffolding solutions that mitigate risks of late thrombosis and in-stent restenosis, compelling healthcare providers to tilt toward these options as the body of clinical evidence advocating their efficacy and safety proliferates. Non-biodegradable polymeric stents remain relevant, providing a compromise with improved biocompatibility and flexibility compared to their metallic counterparts, yet without the dynamic dissolution characteristic. Manufacturers have made substantial strides in enhancing the surface modifications of these stents, which are particularly beneficial in patients requiring sustained support without the concerns of permanent metallic residues. Recent developments in this market emphasize the swift advancement in materials science and a concerted push toward personalized medicine, resulting in the introduction of hybrid stents that combine metallic and polymeric elements to address diverse clinical challenges. Emerging applications capture the imagination of industry players, as novel bioresorbable stents are being deployed experimentally in peripheral artery disease and structural heart interventions, potentially broadening the applicability spectrum beyond coronary pathways. The continual quest to refine stent materials for enhanced patient outcomes catalyzed dynamic cross-industry synergies and reshaped strategies to harness the full spectrum of polymeric technologies. In this evolving ecosystem, metallic stents, with their historical context and established reliability, remain a staple in vascular therapy; however, the relentless pursuit of improved patient care paradigms sees polymeric stents gaining traction as a futuristic modality poised to redefine interventional cardiology. As healthcare providers and payers become increasingly conscious of long-term health costs and quality-of-life considerations, the materials of vascular stents serve as a crucial determinant of therapeutic regime selection, catalyzing an era of nuanced interventional strategies tailored to individual patient profiles.

Porter’s Five Forces Analysis

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Vascular Stent Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

PESTLE Analysis

The PESTLE analysis offers a comprehensive tool for understanding and analyzing the external macro-environmental factors that impact businesses within the Vascular Stent Market. This framework examines Political, Economic, Social, Technological, Legal, and Environmental factors, providing companies with insights into how these elements influence their operations and strategic decisions. By using PESTLE analysis, businesses can identify potential opportunities and threats in the market, adapt to changes in the external environment, and make informed decisions that align with current and future conditions. This analysis helps companies anticipate shifts in regulation, consumer behavior, technology, and economic conditions, allowing them to better navigate risks and capitalize on emerging trends.

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Vascular Stent Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Vascular Stent Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Recent Developments

  • Translumina expands global footprint with UAE operations, leveraging Indian innovation in vascular stents

    Translumina Therapeutics, India's robust coronary stents manufacturer, initiated direct operations in the UAE, aiming to expand its global footprint. This strategic move enhances their presence in the fast-growing MENA region and aligns with their 'Make in India, Make for the World' vision. [Published On: September 21, 2024]

  • R3 Vascular Inc. secures USD 87 million funding, and targets breakthrough in PAD treatment with next-gen bioresorbable scaffold

    R3 Vascular Inc. secured USD 87 million in Series B financing, led by Deerfield Management and with participation from existing investors. The strategy aims to establish R3’s innovative scaffolds as a new standard in PAD treatment, leveraging their strength, flexibility, and bioresorbable sirolimus-coated design to reduce amputation rates and improve patient outcomes globally. [Published On: July 15, 2024]

  • GE HealthCare's 3DStent tackles expansion challenges in complex cases by revolutionizing stent visualization

    The introduction of 3DStent by GE HealthCare marks a significant enhancement in stent visualization technology, allowing three-dimensional imaging using rotational angiography without additional devices. This innovation aims to address challenges in stent expansion, particularly in complex cases with calcified lesions. [Published On: July 09, 2024]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Vascular Stent Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Vascular Stent Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amaranth Medical, Inc., Artivion Inc., B. Braun SE, Becton, Dickinson and Company, Biotronik SE & Co. KG, Blue Sail Medical Co., Ltd, Boston Scientific Corporation, Cardinal Health, Inc., Cook Group Incorporated, Elixir Medical Corporation, Endologix LLC, iVascular, S.L.U, Kaneka Corporation, Kyoto Medical Planning Co., Ltd., Lepu Medical Technology(Beijing)Co.,Ltd., Lombard Medical Ltd., Medtronic PLC, Meril Life Sciences Pvt. Ltd, Microport Scientific Corporation, Otsuka Medical Devices Co., Ltd., Purple MicroPort Cardiovascular Pvt. Ltd, Sahajanand Medical Technologies Limited, Stryker Corporation, Terumo Corporation, Translumina GmbH, and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Vascular Stent Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product Type
    • Balloon-Expandable Stents
    • Self-Expanding Stents
  • Material
    • Metallic Stents
    • Polymeric Stents
      • Biodegradable Polymers
      • Non-Biodegradable Polymers
  • Delivery System
    • Bare Metal Stents
    • Covered Stents
    • Drug Eluting Stents
  • Application
    • Coronary Artery Disease
    • Gastrointestinal Disease
    • Peripheral Artery Disease
      • Lower Extremities
      • Upper Extremities
  • End User
    • Ambulatory Surgical Centers
    • Cardiac Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

This research report offers invaluable insights into various crucial aspects of the Vascular Stent Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?
Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Vascular Stent Market, by Product Type
  7. Vascular Stent Market, by Material
  8. Vascular Stent Market, by Delivery System
  9. Vascular Stent Market, by Application
  10. Vascular Stent Market, by End User
  11. Americas Vascular Stent Market
  12. Asia-Pacific Vascular Stent Market
  13. Europe, Middle East & Africa Vascular Stent Market
  14. Competitive Landscape
360iResearch Analyst Ketan Rohom
Download a Free PDF
Get a sneak peek into the valuable insights and in-depth analysis featured in our comprehensive vascular stent market report. Download now to stay ahead in the industry! Need more tailored information? Ketan is here to help you find exactly what you need.
Frequently Asked Questions
  1. How big is the Vascular Stent Market?
    Ans. The Global Vascular Stent Market size was estimated at USD 10.09 billion in 2023 and expected to reach USD 10.65 billion in 2024.
  2. What is the Vascular Stent Market growth?
    Ans. The Global Vascular Stent Market to grow USD 15.06 billion by 2030, at a CAGR of 5.88%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.